Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia
Review article
[키워드] acute-phase response
Antithrombotic
approach
benefit
Clinical findings
Coagulation
Coagulopathy
contribute
COVID-19
develop
Disseminated intravascular coagulation
Endothelial dysfunction
Health
highlight
hospital discharge
hospitalised patient
implication
increased risk
infected with SARS-CoV-2
Inflammatory response
key consideration
Laboratory
laboratory feature
management
moderate
outcomes
pathophysiology
patients with COVID-19
Pneumonia
prevention
Prophylaxis
proportion
question
SARS-COV-2 infection
severe COVID-19
Support
therapeutic anticoagulation
thromboembolic complications
Thromboprophylaxis
thrombosis
Treatment
Trial
understanding
with COVID-19
[DOI] 10.1016/S2213-2600(21)00455-0 [Article Type] Review article
[DOI] 10.1016/S2213-2600(21)00455-0 [Article Type] Review article